Cargando…

Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment

BACKGROUND: Limited treatment options are available for patients infected with multidrug (MDR)- or pan-drug (PDR)-resistant bacterial pathogens, resulting in infections that can persist for weeks or months. In order to better understand transmission and evolutionary dynamics of MDR Acinetobacter bau...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Meredith S., Iovleva, Alina, Jacobs, Michael R., Bonomo, Robert A., Adams, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776386/
https://www.ncbi.nlm.nih.gov/pubmed/26939581
http://dx.doi.org/10.1186/s13073-016-0279-y
_version_ 1782419144740700160
author Wright, Meredith S.
Iovleva, Alina
Jacobs, Michael R.
Bonomo, Robert A.
Adams, Mark D.
author_facet Wright, Meredith S.
Iovleva, Alina
Jacobs, Michael R.
Bonomo, Robert A.
Adams, Mark D.
author_sort Wright, Meredith S.
collection PubMed
description BACKGROUND: Limited treatment options are available for patients infected with multidrug (MDR)- or pan-drug (PDR)-resistant bacterial pathogens, resulting in infections that can persist for weeks or months. In order to better understand transmission and evolutionary dynamics of MDR Acinetobacter baumannii (Ab) during long-term infection, we analyzed genomes from a series of isolates from individual patients at isolate-specific, patient-specific, and population levels. METHODS: Whole genome analysis of longitudinal isolates (range 2-10 isolates per patient spanning 0-829 days) from 40 patients included detection of single-nucleotide variants (SNVs), insertion sequence (IS) mapping, and gene content changes. RESULTS: Phylogenetic analysis revealed that a significant fraction of apparently persistent infections are in fact due to re-infection with new strains. SNVs primarily resulted in protein coding changes, and IS events primarily interrupted genes or were in an orientation such that the adjacent gene would be over-expressed. Mutations acquired during infection were over-represented in transcriptional regulators, notably pmrAB and adeRS, which can mediate resistance to the last line therapies colistin and tigecycline, respectively, as well as transporters, surface structures, and iron acquisition genes. CONCLUSIONS: Most SNVs and IS events were isolate-specific indicating these mutations did not become fixed on the time scale investigated, yet over-representation of independent mutations in some genes or functional categories suggests that they are under selective pressure. Genome analysis at the population-level suggests that gene transfer including recombination also contributes to Ab evolutionary dynamics. These findings provide important insight into the transmission dynamics of Ab and the identification of patients with repeat infections has implications for infection control programs targeted to this pathogen. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13073-016-0279-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4776386
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47763862016-03-04 Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment Wright, Meredith S. Iovleva, Alina Jacobs, Michael R. Bonomo, Robert A. Adams, Mark D. Genome Med Research BACKGROUND: Limited treatment options are available for patients infected with multidrug (MDR)- or pan-drug (PDR)-resistant bacterial pathogens, resulting in infections that can persist for weeks or months. In order to better understand transmission and evolutionary dynamics of MDR Acinetobacter baumannii (Ab) during long-term infection, we analyzed genomes from a series of isolates from individual patients at isolate-specific, patient-specific, and population levels. METHODS: Whole genome analysis of longitudinal isolates (range 2-10 isolates per patient spanning 0-829 days) from 40 patients included detection of single-nucleotide variants (SNVs), insertion sequence (IS) mapping, and gene content changes. RESULTS: Phylogenetic analysis revealed that a significant fraction of apparently persistent infections are in fact due to re-infection with new strains. SNVs primarily resulted in protein coding changes, and IS events primarily interrupted genes or were in an orientation such that the adjacent gene would be over-expressed. Mutations acquired during infection were over-represented in transcriptional regulators, notably pmrAB and adeRS, which can mediate resistance to the last line therapies colistin and tigecycline, respectively, as well as transporters, surface structures, and iron acquisition genes. CONCLUSIONS: Most SNVs and IS events were isolate-specific indicating these mutations did not become fixed on the time scale investigated, yet over-representation of independent mutations in some genes or functional categories suggests that they are under selective pressure. Genome analysis at the population-level suggests that gene transfer including recombination also contributes to Ab evolutionary dynamics. These findings provide important insight into the transmission dynamics of Ab and the identification of patients with repeat infections has implications for infection control programs targeted to this pathogen. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13073-016-0279-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-03 /pmc/articles/PMC4776386/ /pubmed/26939581 http://dx.doi.org/10.1186/s13073-016-0279-y Text en © Wright et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wright, Meredith S.
Iovleva, Alina
Jacobs, Michael R.
Bonomo, Robert A.
Adams, Mark D.
Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
title Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
title_full Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
title_fullStr Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
title_full_unstemmed Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
title_short Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
title_sort genome dynamics of multidrug-resistant acinetobacter baumannii during infection and treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776386/
https://www.ncbi.nlm.nih.gov/pubmed/26939581
http://dx.doi.org/10.1186/s13073-016-0279-y
work_keys_str_mv AT wrightmerediths genomedynamicsofmultidrugresistantacinetobacterbaumanniiduringinfectionandtreatment
AT iovlevaalina genomedynamicsofmultidrugresistantacinetobacterbaumanniiduringinfectionandtreatment
AT jacobsmichaelr genomedynamicsofmultidrugresistantacinetobacterbaumanniiduringinfectionandtreatment
AT bonomoroberta genomedynamicsofmultidrugresistantacinetobacterbaumanniiduringinfectionandtreatment
AT adamsmarkd genomedynamicsofmultidrugresistantacinetobacterbaumanniiduringinfectionandtreatment